济南会痛风怎么办(山东喝红酒可以降尿酸吗) (今日更新中)

BEIJING, Nov. 27 (Xinhua) -- China's industrial enterprises saw their profits increase 25.3 percent year-on-year in the first ten months of 2011, slowing down from the year's previously recorded figures, official data showed Sunday.Growth in the January-October period was 1.7 percentage points lower from that of the first three quarters, the National Bureau of Statistics (NBS) said in a statement.It marked a gradual downshift from the 34.3-percent year-on-year growth seen during the January-February period and the 28.7-percent growth seen during the first half of the year.Profits realized in the first ten months amounted to 4.12 trillion yuan (650 billion U.S. dollars), the NBS said.The NBS compiled the figures using data collected from a pool of industrial businesses with at least 20 million yuan in annual sales revenues each.In October alone, industrial profits expanded 12.5 percent year-on-year to 438.3 billion yuan, the NBS said.Among 39 industries surveyed, 36 sectors reported profit growth in the first ten months. The oil refining, coking and nuclear-fuel processing sector saw profit plunge 89.8 percent year-on-year.Private businesses posted the fastest profit growth, with a year-on-year rise of 44.3 percent, followed by collectively owned enterprises of 33 percent, equity-holding companies of 30.3 percent, state-owned enterprises of 16.6 percent and overseas-funded firms of 11.6 percent.China's industrial production growth rate will moderate due to economic turmoil in Europe and the United States and weakening domestic demand brought about by a tightened monetary policy, Huang Libin, an official with the Ministry of Industry and Information Technology, said last week.China saw its economic growth slow to 9.1 percent in the third quarter of this year from 9.5 percent in the second quarter and 9.7 percent in the first quarter.

BEIJING, Jan. 1 (Xinhua) -- The public on Sunday strongly echoed Chinese President Hu Jintao's New Year address broadcast on Saturday, vowing to make great efforts for rejuvenation of the nation, a better future.In his speech titled "Jointly Improve World Peace and Development," Hu said that China will continue to develop friendly exchanges with other countries and positively participate in international cooperation on global issues.The country will continue to balance maintaining steady and relatively fast economic growth with adjusting its economic structures and managing inflation expectations, Hu said in the speech.PROUD Of COUNTRY'S ACHIEVEMENTS"We have been encouraged by President Hu's address, said Wang Laihua, head of the public opinions research institute of Tianjin Social Sciences Academy."His address summarized the achievements that we have made in the first year of the 12th Five-Year Plan, which raised people's expectation for prosperity, happiness," said Wang.Hu said in the address that in the face of complicated international situations and arduous tasks in maintaining domestic reform, development and stability in 2011, Chinese people united and continued to push forward the opening up and reform drive and the socialist modernization construction, while maintaining steady and relatively fast economic growth and making progress in building a well-off society in an all-around way.Zhu Jianfang, chief economist of CITIC Securities, said that the country's macroeconomic control has made positive achievements in the last year, as the prices of properties and commodity have been effectively controlled."We feel reassured after hearing Hu's speech," said Wen Jun, who has come to south China's Guangzhou for business from Hong Kong for 16 years, referring to Hu's speech saying that China will stick to the guidelines of "one country, two systems," "Hong Kong people governing Hong Kong," "Macao people governing Macao," and a high degree of autonomy in maintaining the long-term prosperity and stability of Hong Kong and Macao.

BEIJING, Oct. 24 (Xinhuanet) -- There is no evidence to prove that using a cell phone can increase the risks of brain cancer, suggested a lastest study by Danish researchers.To arrive at the result, the researchers examined the health records from 1990 to 2007 for 358,403 Danish cell phone plan subscribers.They found that among people using cell phones for as long as 13 years or more, the cancer risks were almost the same as for non-subscribers.The finding, published in the British Medical Journal last week, alleviated the fear among the world's 5 billion cell phone users.Five months ago, a statement from the World Health Organization's International Agency for Research on Cancer (IARC) sparked fear in cell phone users around the world because it said that cell phone use might cause brain cancer.However, the finding could not rule out the risk of brain cancer triggered by heavy use of cell phones, admitted Patrizia Frei of the Danish Cancer Society's Institute of Cancer Epidemiology, lead author of the study.Frei added, cited by CNN, "There are still some open questions, about greater amounts of use, and about the effects on children."The IARC did not give formal response to the study, but it offered some ways for cell phone consumers to reduce possible risks months ago.Texting and using hands-free sets for voice calls lower exposure to potentially harmful radiation, compared to device-to-ear voice calls, by at least 10-fold, IARC stated, reported by the New York Daily News.

WASHINGTON, Dec. 7 (Xinhua) -- The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.Their report, published on-line Wednesday in Gynecologic Oncology, suggests that this combination, ixabepilone and sunitinib, might offer a much needed treatment option for women with advanced ovarian cancer.Neither drug is approved for use in ovarian cancer. Ixabepilone is a chemotherapy drug that, like other taxane drugs, targets the microtubules and stops dividing cells from forming a spindle. It has been approved for use in metastatic breast cancer. Sunitinib, approved for use in kidney cancer, belongs to a class of tyrosine kinase inhibitors that stops growth signals from reaching inside cancer cells.When caught at late stages, ovarian cancer is often fatal because it progressively stops responding to the chemotherapy drugs used to treat it."Women die from ovarian cancer because their tumors become resistant to chemotherapy, so a drug that might be able to reduce that resistance -- which may be what this combination of agents is doing -- would be a boon to treatment of this difficult cancer," says study coauthor Gerardo Colon-Otero.The finding also highlights the importance of the role of a molecule, RhoB, that the researchers say is activated by the drug duo. It might be a potential biomarker that may help identify patients who might benefit from such combination therapy, the researchers say.

SAN FRANCISCO, Nov. 9 (Xinhua) -- Cisco Systems Inc., the world 's biggest networking equipment maker, on Wednesday reported that its profit fell about 7.9 percent in the most recent quarter.In the company's fiscal 2012 first quarter ending on Oct. 29, Cisco posted its net income of nearly 1.78 billion U.S. dollars, compared with 1.93 billion dollars in the same period a year earlier.Excluding some items, earnings per share in the quarter were 43 cents, better than the 39 cents estimated by analysts, according to Bloomberg.Cisco's sales in the quarter reached 11.26 billion dollars, an increase of 4.7 percent year-on-year and also topped analysts' projection of about 11 billion dollars."We delivered a solid quarter," John Chambers, Cisco's chief executive officer, said in a statement."We've completed the majority of our restructuring and have organized Cisco to successfully execute against our strategy of providing intelligent networks, architectures and integrated products that solve customers' business problems," he added.

来源：资阳报